Elif Yilmaz

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Liso-cel use in B-cell NHL
    Date added:
    11/16/2022
    Date updated:
    09/04/2025
    Relationship end date:
    08/06/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pierre Fabre Pharmaceuticals
    Topic:
    Tab-cel use in PTLD
    Date added:
    09/04/2025
    Date updated:
    09/04/2025
    Relationship end date:
    05/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Epcoritamab use in B-cell NHL
    Date added:
    09/04/2025
    Date updated:
    09/04/2025
    Relationship end date:
    10/25/2025
Return to 109 Division Of Hem/Onc: Combined Modality Conference "Academic Half Day" (042326)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.